GLP-3 RT 10mg

Product Description:
This is a synthetic peptide analog supplied in lyophilized powder form for use in qualified laboratory environments. The compound is intended exclusively for in vitro and analytical research applications involving peptide interaction and assay-based systems under controlled experimental conditions. This material is provided strictly for research use only and has not been evaluated for clinical, therapeutic, or diagnostic use.
Product Designation Note:
This product is identified using an internal designation for cataloging and differentiation purposes. It is not marketed, labeled, or represented as any approved pharmaceutical or therapeutic compound.
Research Applications:
In controlled laboratory research settings, this peptide analog is utilized to support investigation of:

Receptor binding interaction modeling involving modified peptide analogs
Comparative evaluation of synthetic peptide conjugation strategies
Structural integrity, degradation kinetics, and stability analysis
Screening assay development and analytical evaluation in controlled experimental systems
All research activities are conducted in non-human, non-clinical experimental models.

Storage and Handling:
Store the lyophilized powder at -20°C.
Once reconstituted, store at 2-8°C and use promptly.
Maintain aseptic handling practices to ensure product quality and sterility.
Product Specifications:
Purity: ≥99% (HPLC Certified)
Appearance: Lyophilized white powder
Solubility: Soluble in suitable laboratory agents
Compliance Notice:
This compound is FOR RESEARCH USE ONLY as an analytical reference material. The structural characteristics of this compound correspond to the peptide (LY3437943), a synthetic multi-receptor agonist (GLP-1/GIP/glucagon receptor) currently under clinical investigation and not approved by the FDA for any indication. This research material is not the investigational drug product, is not intended for human or veterinary use, and has not been independently evaluated by the FDA as a research compound. Misuse of this product is strictly prohibited and may violate federal, state, or local laws. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.

GLP-3 RT is the research designation for LY3437943. It acts on three receptors at once: GLP-1, GIP, and glucagon. Research has examined how it affects metabolism, energy use, and blood sugar in study models. Most similar compounds hit only two receptors. The third target is what sets this one apart.

Formula
C221H342N50O68
Mol. weight
4731.32 Da
Length
39 residues
Purity
≥99% (HPLC verified)

This is a synthetic peptide analog supplied in lyophilized powder form for use in qualified laboratory environments. The compound is intended exclusively for in vitro and analytical research applications involving peptide interaction and assay-based systems under controlled experimental conditions. This material is provided strictly for research use only and has not been evaluated for clinical, therapeutic, or diagnostic use.